Sildenafil and calcitonin gene-related peptide dilate intradural arteries: A 3T MR angiography study in healthy volunteers. (February 2019)

• Record Type: Journal Article
• Authors: Christensen, Casper Emil; Amin, Faisal Mohammad; Younis, Samaira; Lindberg, Ulrich; de Koning, Patrick; Petersen, Esben Thade; Paulson, Olaf Bjarne; Larsson, Henrik Bo Wiberg; Ashina, Messoud
• Is Part Of: Cephalalgia. Volume 39:Number 2(2019)
• Page Start: 264
• Page End: 273
• Publication Date: 2019-02
• Subjects: Neuroimaging -- middle meningeal artery -- human migraine models; Headache -- Periodicals; 616.8491
• DOI: 10.1177/0333102418787336
• Languages: English
• ISSNs: 0333-1024

Abstract

Background: Sildenafil and calcitonin gene-related peptide are vasoactive substances that induce migraine attacks in patients. The intradural arteries are thought to be involved, but these have never been examined in vivo . Sildenafil is the only migraine-inducing compound for which cephalic, extracranial artery dilation is not reported. Here, we investigate the effects of sildenafil and calcitonin gene-related peptide on the extracranial and intradural parts of the middle meningeal artery. Methods: In a double-blind, randomized, three-way crossover, placebo-controlled head-to-head comparison study, MR-angiography was recorded in healthy volunteers at baseline and twice after study drug (sildenafil/ calcitonin gene-related peptide/saline) administration. Circumferences of extracranial and intradural middle meningeal artery segments were measured using semi-automated analysis software. The area under the curve for circumference change was compared using paired t-tests between study days. Results: Twelve healthy volunteers completed the study. The area under the curveBaseline-120min was significantly larger on both the sildenafil and the calcitonin gene-related peptide day in the intradural middle meningeal artery (calcitonin gene-related peptide, p = 0.013; sildenafil, p = 0.027) and the extracranial middle meningeal artery (calcitonin gene-related peptide, p = 0.0003; sildenafil, p = 0.021), compared to placebo. Peak intradural middle meningeal artery dilation was 9.9% (95% CI [2.9–16.9]) after sildenafil (T30min ) and 12.5% (95% CI [8.1–16.8]) after calcitonin gene-related peptide (T30min ). Peak dilation of the extracranial middle meningeal artery after calcitonin gene-related peptide (T30min ) was 15.7% (95% CI [11.2–20.1]) and 18.9% (95% CI [12.8–24.9]) after sildenafil (T120min ). Conclusion: An important novel finding is that both sildenafil and calcitonin gene-related peptide dilate intradural arteries, supporting the notion that all known pharmacological migraine triggers dilate cephalic vessels. We suggest that intradural artery dilation is associated with headache induced by calcitonin gene-related peptide and sildenafil.